Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity treatments continue to improve.

A senior US medic said the risk had led him to think twice before taking them, consider alternatives and only use the lowest ...

Millions of Americans rely on GLP-1 drugs to improve their health, but bad actors are peddling dangerous fakes.” ...

The increasing prevalence of chronic conditions like cardiovascular disease is driving the demand for transmucosal drugs. Key factors contributing to the transmucosal drugs market's growth from ...

DelveInsight's Transmucosal Drugs Market Insights report provides the current and forecast market analysis, individual ...